Although high serum 25(OH)D levels were recently found to be associated with a reduced risk of asthma-related symptoms, such as wheeze (10), this may be explained by reduced respiratory infections alone (10-13). The impact of 25(OH)D on the development of actual asthma is unclear. To date, there are few prospective studies on serum 25(OH)D levels and incident asthma and they have yielded mixed findings, and focused primarily on children (10, 14-16). A recent cross-sectional study observed a significant association between lower serum 25(OH)D level and a higher risk of ever asthma diagnosis among non-atopic but not atopic individuals (17). In the present study, we evaluated the association between baseline serum 25(OH)D levels and incident asthma among adults in the Nord-Trøndelag Health Study (HUNT) in Norway. We also explored possible effect-modification by allergy status.
The relationship between vitamin D status and asthma development is highly controversial;
Wjst claims that asthma is caused by vitamin D supplementation (1) , while Litonjua and Weiss assert that asthma is caused by vitamin D deficiency (2) integrates all sources of vitamin D and is the best available approach to determine the body vitamin D status (9) .
Although high serum 25(OH)D levels were recently found to be associated with a reduced risk of asthma-related symptoms, such as wheeze (10) , this may be explained by reduced respiratory infections alone (10) (11) (12) (13) . The impact of 25(OH)D on the development of actual asthma is unclear. To date, there are few prospective studies on serum 25(OH)D levels and incident asthma and they have yielded mixed findings, and focused primarily on children (10, (14) (15) (16) . A recent cross-sectional study observed a significant association between lower serum 25(OH)D level and a higher risk of ever asthma diagnosis among non-atopic but not atopic individuals (17) . In the present study, we evaluated the association between baseline serum 25(OH)D levels and incident asthma among adults in the Nord-Trøndelag Health Study (HUNT) in Norway. We also explored possible effect-modification by allergy status.
MATERIALS AND METHODS

Study design
HUNT is the largest and most comprehensive population health survey in Norway (18) . The adult part of the HUNT invited all inhabitants aged 19 years or older in the county of NordTrøndelag in the 3 separate surveys: HUNT 1 (1984-86) , HUNT 2 (1995-97) and HUNT 3 (2006-08) . In the current study, we used data from HUNT 2 and HUNT 3. Briefly, HUNT 2 invited about 93,000 adults in 1995-97, and 65,215 subjects participated (response rate: 70%).
Among them, 57% (n = 37,059) took part in HUNT 3 in 2006-08. We established a cohort population that included all subjects who participated in both HUNT 2 and HUNT 3 and were less than 65 years of age in HUNT 3 (n = 25,616) (Figure 1 ). The age limit was set to decrease the possibility of misclassification of asthma and chronic obstructive pulmonary disease (COPD).
The cohort population answered the same questions regarding wheeze and asthma in HUNT 2 and HUNT 3, i.e. "Have you had attacks of wheezing or breathlessness during the last 12 months" and "Do you have or have you had asthma?" Subjects who reported no wheeze or asthma in HUNT 2 but reported asthma in HUNT 3 were regarded as incident asthma cases.
To study the association between baseline serum 25(OH)D level and incident asthma, a nested case-control study was carried out including all incident asthma cases (n = 600) during an average 11-year follow up and a number of non-asthma controls (n = 2,013). The non-asthma control group was taken from a 10% random sample of the cohort population (n = 2,584) after excluding those who had wheeze or asthma in either HUNT 2 or HUNT 3 ( Figure 1 ). This 10% random sample was originally chosen for other research purposes in the HUNT study.
The size of the random sample was decided upon economic and logistic reasons. We estimated before conducting the study that a sample size of 600 cases and 2,000 controls would allow us to detect an approximate 20% increase in asthma risk associated with low serum 25(OH)D concentration at the α = 0.05 and 1-β = 0.85 levels, with no consideration of potential effect modification. Among the sampled cases and controls, there were 584 incident asthma cases and 1,958 non-asthma controls whose blood specimens collected in HUNT 2 were available and sufficient for the measurement of 25(OH)D levels ( Figure 1 
Statistical analysis
The statistical analyses were performed in women and men separately to allow identification of asthma risk factors that may be specific to one sex only based on a priori assumption (20) .
Baseline characteristics were compared between incident asthma cases and non-asthma controls: un-paired t-tests were used for continuous variables; Chi-square tests were used for categorical variables. Baseline serum 25(OH)D levels were treated as continuous values and also classified into 3 groups: <50.0, 50.0-74.9, and ≥75.0 nmol/L (equivalent to <20.0, 20.0-29.9, and ≥30.0 ng/ml), which are widely used cut-off points in scientific literature (10, 21, 22) . The association between 25(OH)D and incident asthma was examined by using logistic regression analyses, and odds ratios (OR) and 95% confidence intervals (CI) were calculated.
Multivariable logistic regression models included age, daily smoking, family history of asthma, education, physical activity, social benefit, economic difficulties and body mass index categories at baseline as potential risk factors for asthma. All these covariates were coded as categorical variables including the "unknown" group. The analyses were further stratified by allergic rhinitis (yes/no/missing). Since there were a number of subjects with missing information on allergic rhinitis (n = 269 for women and n = 277 for men), we performed 2 sensitivity analyses in women and men respectively by placing the "missing" group with subjects who either did or did not report having allergic rhinitis. To examine the potential misclassification for reported asthma, we repeated the analysis by excluding those who reported having doctor-diagnosed COPD, and by using a stricter asthma definition that required reported asthma in combination with using inhaled corticosteroids alone or combined with long-acting beta2-agonists during the last year (in Norway, asthma diagnosis was always confirmed by a doctor when adult patients were prescribed asthma medication). We also used a stricter definition for allergic rhinitis: i.e. reported having allergic rhinitis and/or hay fever in combination with an affirmative response to a question on allergy condition (symptoms from lung, nose or eyes when exposed to pets, pollen or dust) in a subsequent interview; the stricter definition for no allergic rhinitis was negative answers to both questions; subjects who met only 1 criterion were not included in the analysis. Statistical significance was set at 2-tailed P <0.05, except for P interaction where P <0.10 was used. All statistical analyses were performed with STATA, release 12.0 (College Station, Texas, USA) (23).
Ethics
The study was approved by the Regional Committee for Medical Research Ethics. All participants gave their informed consent. Table 1 shows the differences in baseline characteristics between incident asthma cases and non-asthma controls. Asthma cases compared with controls had a higher mean value of body mass index but a lower mean value of serum 25(OH)D in both women and men. Asthma cases were more likely to have a family history of asthma, less years of education and lower socioeconomic status than controls. However, there were no differences in age, physical activity or season for blood sampling between cases and controls. Among women only, asthma cases were more likely to be smokers than the non-asthma controls.
RESULTS
For baseline serum 25(OH)D levels, 45% of the asthma cases vs. 37% of the controls had a level below 50.0 nmol/L in women, and in men they were 47% and 41%, respectively ( Table   2 ). The unadjusted analysis for women revealed a non-significant increase in asthma risk with In men without allergic rhinitis by the stricter definition (i.e. men who reported no allergic rhinitis or hay fever in the questionnaire and who also confirmed their lack of allergy in the subsequent interview, n = 427), each 25 nmol/L reduction in 25(OH)D level was significantly associated with an increased risk of asthma (AOR = 1.75 , 95% CI: 1.12, 2.70 ), but the associations remained non-significant in men with allergic rhinitis (n = 100) and in women with (n = 199) or without (n = 547) allergic rhinitis using the stricter definition.
DISCUSSION
Our study is one of the first large prospective studies evaluating the association between serum 25(OH)D levels and incident asthma in adults. We observed no significant association between serum 25(OH)D levels and incident asthma among women, nor among men with allergic rhinitis. However, we did find a significant inverse association between serum 25(OH)D level and risk of incident asthma among men without allergic rhinitis.
Previous prospective studies were mostly conducted in children and the findings were inconsistent (10, (14) (15) (16) . A birth cohort study from New Zealand demonstrated that 25(OH)D in cord blood was inversely associated with the risk of respiratory infection and wheeze, but not with asthma by the age of 5 years (10). Another birth cohort study conducted in Tucson, Arizona, observed that both low and high levels of cord blood 25(OH)D levels were associated with increased levels of total IgE and specific IgE to aeroallergens, but not with allergic rhinitis or asthma at 5 years of age (16) . A United Kingdom study actually found an increased risk of asthma in children whose mothers had higher 25(OH)D concentrations during pregnancy (14) . However, large loss of follow-up in the UK study poses concerns;
among the original cohort with available maternal 25(OH)D levels, only 38% of the children were followed up to 9 years of age. By contrast, in a recent publication children (particularly boys) with inadequate vitamin D at 6 years of age were at an increased risk of developing bronchial hyperresponsiveness and asthma at 14 years of age (15) .
Our finding of a significant inverse association in men without allergic rhinitis is in line with the earlier mentioned cross-sectional study which found an association between low serum 25(OH)D levels and asthma in non-atopic subjects only (17) . If the association is causal, the contribution of low vitamin D status on asthma development is more likely via non-allergic than allergic pathways. There is growing appreciation that asthma is a complex trait caused by multiple environmental factors in combination with more than 100 major and minor susceptibility genes and has many different forms or phenotypes (24) (25) (26) . Immunological mechanisms and risk factors for allergic and non-allergic asthma can be quite different, with allergic asthma characterized by eosinophilic inflammation dependent on T helper 2 cells, while non-allergic asthma has neutrophilic inflammation independent of T helper 2 cells (26).
Allergen exposure is the predominant risk factor for allergic asthma, while the risk factors for non-allergic asthma are diverse, such as environmental factors associated with air pollutants and occupation, viral infection, stress, obesity and many unknown factors (26) . Nevertheless, the reasons for an association of low 25(OH)D with asthma only in men without allergic rhinitis (but not in women without allergic rhinitis) are not obvious. This sex difference might also reflect the heterogeneity of non-allergic asthma in men and women with distinct phenotypes predisposed to different origins. Although it is most unlikely, we cannot completely rule out that the non-allergic "asthma" was simply recurrent respiratory infections.
Vitamin D deficiency is shown to be associated with impaired innate immunity, reduced antimicrobial peptide cathelicidin (27, 28) and increased susceptibility to respiratory infections (10, 11, 13) . The sex-specificity could be explained, in part, by the greater vulnerability to infections in males than females (29, 30) .
Our nested case-control study design links serum 25(OH)D levels at baseline with newly developed asthma during the follow-up with a clear directionality for the association of interest. Selection bias would be less likely when population-based incident asthma cases and non-asthma controls were selected. Furthermore, we performed sensitivity analyses to make sure that missing on allergic rhinitis had no important impact on our main results.
We acknowledge that the study has several potential limitations. Firstly, there remains possibility for asthma to be misclassified although reported-asthma is the most common approach in epidemiological studies (12, 31) . However, analyses that excluded subjects with a Multivariable logistic regression model included age (19-29, 30-39, 40-49 , and 50-55 years), daily smoking (yes, no, and unknown), family history of asthma (yes, no, and unknown), education (<10, 10-12, ≥13 years, and unknown), physical activity (<1, 1-2, ≥3 hours per week, and unknown), social benefit (yes, no, and unknown), economic difficulties (yes, no, unknown) and body mass index (<25.0, 25.0-29.9, and ≥30.0 kg/m 2 ) at baseline.
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